Findings

What do systematic reviews say?

2,536 questions · 2,637 findings · 315 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 608 · 23.1%GRADE not reported 488 · 18.5%Very low 688 · 26.1%Low 540 · 20.5%Moderate 249 · 9.4%High 64 · 2.4%

Clobetasol propionate cream vs prednisone

Quality of life ‐ not measured · bullous pemphigoid

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for bullous pemphigoid 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Clobetasol propionate cream vs prednisone

Adverse events: severe complications at day 21 · bullous pemphigoid

Clobetasol propionate cream may leads to lower adverse events: severe complications at day 21 compared with oral prednisone (low certainty).

1 finding from 1 review

Interventions for bullous pemphigoid 2023 · Cochrane Headline outcomes only
RR 0.65 [0.5, 0.86]
1 study · 341 participants
Low

Doxycycline vs prednisolone

Disease control · bullous pemphigoid

Doxycycline leads to lower disease control at 6 weeks (unadjusted raw data) compared with prednisolone (high certainty).

1 finding from 1 review

Interventions for bullous pemphigoid 2023 · Cochrane Headline outcomes only
RR 0.81 [0.72, 0.92]
1 study · 213 participants
High

Standard interferon plus ribavirin vs standard interferon

Death · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Standard interferon plus ribavirin vs standard interferon

Relapse Number of participants having recurrence after stopping · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Standard interferon plus ribavirin vs standard interferon

End‐of‐treatment response · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Standard interferon plus ribavirin vs standard interferon

Sustained virological response · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Standard interferon plus ribavirin vs standard interferon

Treatment discontinuation · patients on HD with HCV infection

Standard interferon plus ribavirin may leads to higher treatment discontinuation compared with standard interferon alone (low certainty).

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 2.97 [1.19, 7.36]
1 study · 52 participants
Low

Standard interferon plus ribavirin vs standard interferon

Adverse events · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pegylated interferon plus ribavirin vs pegylated interferon alone

Death · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pegylated interferon plus ribavirin vs pegylated interferon alone

Relapse Number of participants having recurrence after stopping · patients on HD with HCV infection

Pegylated interferon plus ribavirin may leads to lower relapse(recurrence after stopping) compared with pegylated interferon alone (low certainty).

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 0.33 [0.23, 0.48]
1 study · 377 participants
Low

Pegylated interferon plus ribavirin vs pegylated interferon alone

End‐of‐treatment response · patients on HD with HCV infection

Pegylated interferon plus ribavirin showed no clear difference in end‐of‐treatment response compared with pegylated interferon alone (low certainty).

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 1.01 [0.94, 1.09]
1 study · 377 participants
Low

Pegylated interferon plus ribavirin vs pegylated interferon alone

Sustained virological response · patients on HD with HCV infection

Pegylated interferon plus ribavirin may leads to higher sustained virological response compared with pegylated interferon alone (low certainty).

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 1.8 [1.46, 2.21]
1 study · 377 participants
Low

Pegylated interferon plus ribavirin vs pegylated interferon alone

Treatment discontinuation · patients on HD with HCV infection

Pegylated interferon plus ribavirin showed no clear difference in treatment discontinuation compared with pegylated interferon alone (low certainty).

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 1.71 [0.69, 4.24]
1 study · 377 participants
Low

Pegylated interferon plus ribavirin vs pegylated interferon alone

Adverse events · patients on HD with HCV infection

Pegylated interferon plus ribavirin may leads to higher adverse events compared with pegylated interferon alone (low certainty).

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 1.1 [1.01, 1.19]
1 study · 377 participants
Low

Hormonal therapy vs placebo or no intervention

Estrogen + progestogens · symptomatic or early postmenopausal women1.

The review found no eligible studies for this question.

1 finding from 1 review

Hormone therapy for sexual function in perimenopausal and postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Application of heat vs application of cold

At least a clinically significant reduction in pain within 6 hours Reported in studies as: clinically improved or reduced pain,a or cessation of pain at end of treatmentb · people stung accidentally by bluebottle jellyfish (Physalia) and box jellyfish that do not cause Irukandji syndrome (Hawaiian box…

It is very uncertain whether application of heat changes at least a clinically significant reduction in pain within 6 hours… compared with application of cold (very low certainty).

1 finding from 1 review

Interventions for the symptoms and signs resulting from jellyfish stings 2023 · Cochrane Headline outcomes only
RR 2.25 [1.42, 3.56]
2 studies · 142 participants
Very low

Intervention not reported

Clinically significant reduction in pain · people stung accidentally by box jellyfish that do not cause Irukandji syndrome (Hawaiian box jellyfish; Carybdea alata) and healthy…

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the symptoms and signs resulting from jellyfish stings 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Cessation of pain at end of treatmenta · people stung accidentally by box jellyfish that do not cause Irukandji syndrome (Hawaiian box jellyfish; Carybdea alata) and healthy…

1 finding from 1 review

Interventions for the symptoms and signs resulting from jellyfish stings 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 62 participants
Very low

Intervention not reported

Dermatological signs up to 1 week after the sting · people stung accidentally by box jellyfish that do not cause Irukandji syndrome (Hawaiian box jellyfish; Carybdea alata) and healthy…

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the symptoms and signs resulting from jellyfish stings 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found